Literature DB >> 7907479

Anti-endothelial antibodies in Takayasu arteritis.

D Sima1, B Thiele, A Turowski, K Wilke, F Hiepe, D Volk, N Sönnichsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7907479     DOI： 10.1002/art.1780370323

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Two Takayasu arteritis patients successfully treated with rituximab.

Authors:  E Caltran; G Di Colo; G Ghigliotti; R Capecchi; E Catarsi; I Puxeddu; P Migliorini; A Tavoni
Journal:  Clin Rheumatol       Date:  2014-01-31       Impact factor: 2.980

2.  Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis.

Authors:  H Ihn; S Sato; M Fujimoto; A Igarashi; N Yazawa; M Kubo; K Kikuchi; K Takehara; K Tamaki
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

3.  Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis.

Authors:  S Kumar Chauhan; N Kumar Tripathy; N Sinha; M Singh; S Nityanand
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

4.  Identification of 4-Trimethylaminobutyraldehyde Dehydrogenase (TMABA-DH) as a Candidate Serum Autoantibody Target for Kawasaki Disease.

Authors:  Atsuko Matsunaga; Yutaka Harita; Yoshio Shibagaki; Nobutaka Shimizu; Kazuhiko Shibuya; Hiroshi Ono; Hitoshi Kato; Takashi Sekine; Naoko Sakamoto; Takashi Igarashi; Seisuke Hattori
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

5.  Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis.

Authors:  Tomoyuki Mutoh; Tsuyoshi Shirai; Tomonori Ishii; Yuko Shirota; Fumiyoshi Fujishima; Fumiaki Takahashi; Yoichi Kakuta; Yoshitake Kanazawa; Atsushi Masamune; Yoshikatsu Saiki; Hideo Harigae; Hiroshi Fujii
Journal:  Nat Commun       Date:  2020-03-09       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.